Physician profile
Eneida Harrison
NPI 1174934004
$19,232.10
in general payments reported to CMS, 2019-2025
28 companies · $4,903 in 2025
The $4,903 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,552 · 2020: $17.06 · 2021: $55.81 · 2022: $1,085 · 2023: $2,556 · 2024: $1,063 · 2025: $4,903.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,031 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,750 · Travel and Lodging: $1,473 · Consulting Fee: $200 · Education: $68.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,031.04 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,750.00 |
| Travel and Lodging | $1,472.75 |
| Consulting Fee | $200.00 |
| Education | $68.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $9,556.53 | 2019-2025 | Ofev, Jascayd |
| Fisher & Paykel Healthcare INC | $3,585.25 | 2022-2025 | Fisher & Paykel Healthcare |
| Zoll Respicardia, INC. | $1,812.56 | 2023-2025 | Remede System |
| Inspire Medical Systems, INC. | $1,212.71 | 2022-2025 | Inspire |
| Astrazeneca Pharmaceuticals Lp | $750.37 | 2022-2025 | Fasenra, Tezspire, Breztri |
| Glaxosmithkline, LLC. | $501.46 | 2022-2025 | Trelegy Ellipta, Nucala |
| Harmony Biosciences LLC | $397.75 | 2020-2024 | Wakix |
| Baxter Healthcare | $221.08 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Avadel Cns Pharmaceuticals, LLC | $200.00 | 2025 | Lumryz |
| Grifols USA, LLC | $112.94 | 2024-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $107.62 | 2023-2024 | Dupixent |
| Genentech USA, INC. | $99.99 | 2019 | |
| Axsome Therapeutics, INC. | $90.58 | 2023 | Sunosi |
| Insmed, INC. | $88.38 | 2022-2025 | Arikayce, Brinsupri |
| Idorsia Pharmaceuticals US INC | $69.05 | 2023 | Quviviq |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $64.19 | 2022-2023 | Yupelri |
| Philips North America LLC | $61.06 | 2022-2023 | |
| Eurofins Viracor, LLC | $43.95 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.00 | 2023 | Glassia |
| E.R. Squibb & Sons, L.L.C. | $36.31 | 2023 | Camzyos |
| Genzyme Corporation | $34.47 | 2025 | |
| Ucb, INC. | $29.77 | 2025 | Briviact |
| Amgen INC. | $25.71 | 2022 | |
| 3b Medical, INC. | $23.03 | 2024 | Luna |
| Alexion Pharmaceuticals, INC. | $20.05 | 2022 | |
| Resmed Corp | $16.72 | 2021 | |
| Itamar Medical INC | $14.17 | 2023 | Watchpatone |
| Nabriva Therapeutics, Plc | $13.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eneida Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.